Quantcast
Last updated on April 16, 2014 at 13:01 EDT

Latest Clinical trial Stories

2014-01-07 08:29:32

Health Economic Analysis Published in the Journal of Hypertension MINNEAPOLIS, Jan. 7, 2014 /PRNewswire/ -- CVRx, Inc., a privately held medical device company, today announced findings from a health-economic analysis published in the Journal of Hypertension that indicates Barostim Therapy is a cost-effective treatment option for patients with drug resistant hypertension. Based on blood pressure reductions attained with Barostim therapy, the Markov model used for this analysis projected that...

2014-01-06 23:20:16

Industry’s Most Comprehensive Cardiac Safety, Respiratory and COA/eCOA Consultants Deliver Valuable Services to Global Biopharmaceutical Customers Philadelphia, PA (PRWEB) January 06, 2014 ERT, a leading global solution provider for high-quality patient safety and efficacy endpoint data collection, today announced an expansion to its cardiac safety, respiratory, and Clinical Outcome Assessment (COA)/electronic COA (eCOA) consulting group. Matthew Reaney joins ERT as a scientific and...

2014-01-06 08:27:52

MANHATTAN BEACH, Calif., Jan. 6, 2014 /PRNewswire/ -- January marks the annual observance of National Pancreatic Cancer Clinical Trials Awareness Month. The five year survival rate of pancreatic cancer is just six percent. In the effort to highlight the urgent need to improve the survival rate for this disease, the Pancreatic Cancer Action Network is educating the public about clinical trials and the critical role they play in making scientific progress. (Logo:...

2014-01-06 08:26:21

SAN DIEGO, Jan. 6, 2014 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the company is scheduled to present a corporate overview at the 32nd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2014, at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) at The Westin St. Francis Hotel in San Francisco, California. A live audio webcast of the presentation will be available under the investor relations section of Arena's website at...

2014-01-06 08:26:19

- Statistically significant improvement in key parameters of heart function, including left ventricular ejection fraction and cardiac output SAN DIEGO, Jan. 6, 2014 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX) today announced that, in a placebo-controlled, nonclinical model of chronic heart failure, MST-188 demonstrated a statistically significant improvement in numerous parameters of heart function, including left ventricular ejection fraction and end-systolic volume,...

2014-01-05 23:03:02

RadioMedix, Inc. is proud to announce that the company has received approval of “Orphan Drug Designation” for 68Ga-DOTATATE (GalioMedix ™) as a diagnostic agent for the management of patients with neuroendocrine tumors (NETs) by U.S Food and Drug Administration (FDA). Houston, TX (PRWEB) January 05, 2014 RadioMedix, Inc. is proud to announce that the company has received approval of “Orphan Drug Designation” for 68Ga-DOTATATE (GalioMedix ™) as a diagnostic agent for the...

2014-01-04 23:21:13

Therapist Al R. Zia of Natural-Med therapy in Ann Arbor is approved by NIH & IRB to conduct clinical research on the effect of CranioSacral integrative therapy on Parkinson's disease. Now recruiting patients for clinical trial & offering complimentary treatment during clinical trial for Parkinson's & cancer sufferers. Ann Arbor, MI (PRWEB) January 03, 2014 The Natural-Med Therapy clinic for CranioSacral integrated therapy is a therapy center for Parkinson's, Cancer...

2014-01-02 04:20:27

Initiative designed to facilitate data sharing in support of advancing biomedical research QUINCY, Mass., Jan. 2, 2014 /PRNewswire/ -- ideaPoint, Inc., a leading provider of partnering and collaboration systems for global enterprises, today announced the availability of a new portal providing a secure system for researchers to request access to anonymized, patient-level clinical trial data provided by sponsor organizations (clinicalstudydatarequest.com). Study sponsors who have...

2013-12-31 23:23:39

Medrio’s eClinical Software praised by customers for being ideal for Phase 1 studies. San Francisco, CA (PRWEB) December 31, 2013 Medrio, a leading Software as a Service (SaaS) provider of electronic data capture (EDC) software is lauded by customers for providing an advanced EDC solution that is ideal for Phase 1 clinical studies. Medrio’s affordable EDC software enables customers to build and deploy studies within days and includes features perfect for Phase 1 studies. These...

2013-12-31 23:04:24

MarketResearchReports.Biz announces addition of new report “Future of the Syrups and Spreads Market in the United Kingdom to 2017” to its database. Visit: http://www.marketresearchreports.biz/analysis-details/apaxis-medical-inc-product-pipeline-analysis-2013-update. Albany, NY (PRWEB) December 31, 2013 Apaxis Medical, Inc. (Apaxis Medical) is a medical device company. The company develops tools and techniques, and develops surgical methods of implanting left ventricular assist devices...